Mutations in the TP53 gene and protein expression of p53, MDM 2 and p21/WAF-1 in primary cervical carcinomas with no or low human papillomavirus load
1998

Mutations in the TP53 Gene in Cervical Carcinomas with Low HPV Load

Sample size: 19 publication Evidence: moderate

Author Information

Author(s): A Helland, F Karlsen, EU Due, R Holand, G Kristensen, A-L Borresen-Dale

Primary Institution: The Norwegian Radium Hospital

Hypothesis

Is p53 inactivation essential in the development of cervical carcinomas with low or no HPV load?

Conclusion

The study found a significant mutation frequency in the TP53 gene among cervical carcinomas with low or no HPV load.

Supporting Evidence

  • 42% of the samples showed mutations in the TP53 gene.
  • Elevated p53 protein expression was significantly associated with the presence of a mutation.
  • 16 out of 19 carcinomas showed p21 protein expression.

Takeaway

This study looked at cervical cancer samples with little or no HPV and found that many had mutations in a gene called TP53, which is important for stopping cancer.

Methodology

The study analyzed 19 cervical carcinoma samples for TP53 mutations and protein expression using CDGE and immunohistochemistry.

Limitations

The study only included samples with low or no HPV load, which may not represent all cervical carcinomas.

Participant Demographics

Patients with primary cervical carcinomas admitted to the Department of Gynaecological Oncology from 1988 to 1993.

Statistical Information

P-Value

p<0.007

Statistical Significance

p<0.001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication